These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 11641519

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis.
    Scorpio A, Lindholm-Levy P, Heifets L, Gilman R, Siddiqi S, Cynamon M, Zhang Y.
    Antimicrob Agents Chemother; 1997 Mar; 41(3):540-3. PubMed ID: 9055989
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Genetic and phenotypic characterization of pyrazinamide-resistant mycobacterium tuberculosis complex isolates in Japan.
    Miyagi C, Yamane N, Yogesh B, Ano H, Takashima T.
    Diagn Microbiol Infect Dis; 2004 Feb; 48(2):111-6. PubMed ID: 14972380
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan.
    Khan MT, Malik SI, Ali S, Masood N, Nadeem T, Khan AS, Afzal MT.
    BMC Infect Dis; 2019 Feb 06; 19(1):116. PubMed ID: 30728001
    [Abstract] [Full Text] [Related]

  • 10. Mycobacterium tuberculosis genotypic diversity in pyrazinamide-resistant isolates of Iran.
    Doustdar F, Khosravi AD, Farnia P.
    Microb Drug Resist; 2009 Dec 06; 15(4):251-6. PubMed ID: 19857130
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada.
    Cheng SJ, Thibert L, Sanchez T, Heifets L, Zhang Y.
    Antimicrob Agents Chemother; 2000 Mar 06; 44(3):528-32. PubMed ID: 10681313
    [Abstract] [Full Text] [Related]

  • 14. New mutations in pncA of in vitro selected pyrazinamide-resistant strains of Mycobacterium tuberculosis.
    Bamaga M, Zhang H, Wright DJ.
    Microb Drug Resist; 2001 Mar 06; 7(3):223-8. PubMed ID: 11759083
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Estimation of pyrazinamidase activity using a cell-free In vitro synthesis of pnca and its association with pyrazinamide susceptibility in Mycobacterium tuberculosis.
    Rueda D, Bernard C, Gandy L, Capton E, Boudjelloul R, Brossier F, Veziris N, Zimic M, Sougakoff W.
    Int J Mycobacteriol; 2018 Mar 06; 7(1):16-25. PubMed ID: 29516881
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.